Related by context. All words. (Click for frequent words.) 72 eTag assays 70 methylation markers 70 Corus CAD 69 PROLARIS 68 therapeutic regimens 68 deCODE ProstateCancer TM 68 OnDose 68 molecular biomarkers 67 kidney urologic 67 deCODE AF TM 67 allogeneic HSCT 66 neovascular diseases 66 Oncotype DX colon cancer 66 PLAC test 66 CYT# potent vascular disrupting 66 therapeutic radiopharmaceuticals 66 K ras mutations 65 deCODE BreastCancer TM 65 differentiate squamous 65 Septin9 65 pharmacogenetic tests 65 HER2 overexpression 65 fusion enhancers 65 oral picoplatin 65 Lung transplantation 65 TOCOSOL Camptothecin 65 antiangiogenic agents 65 ADVEXIN therapy 64 endocrine therapies 64 diagnostic prognostic 64 metastatic neuroendocrine tumors 64 HIV HCV coinfected 64 thoracoscopic lobectomy 64 unresectable tumors 64 KRAS mutation 64 CINQUIL 64 Oncotype 64 Renal Cell Carcinoma RCC 64 deCODE BreastCancer 64 CTAP# Capsules 64 mutated K ras 64 ADME properties 64 MammaPrint R 64 preclinically 64 autologous hematopoietic stem cell 64 antiplatelet therapies 64 microRNA biomarkers 64 hereditary emphysema 64 immunotherapeutic approaches 64 Panzem R NCD 64 biomarker identification 64 CINtec ® PLUS 64 IMA# 64 predictive biomarkers 63 DNA methylation patterns 63 intra arterial chemotherapy 63 LHRH antagonists 63 AGHD 63 recurrent metastatic ovarian cancer 63 GenPath 63 molecularly targeted therapies 63 VerifyNow 63 LungAlert TM 63 genetic biomarkers 63 Epigenomics proprietary 63 Virulizin ® 63 EGFR mutation status 63 TroVax ® 63 relapsed MM 63 Thalomid ® 63 bladder ovarian 63 NSCLC tumors 63 serum biomarkers 63 prognostic markers 63 stratifying patients 63 p# biomarker 63 theranostic 63 metastatic pancreatic 63 commercialize deforolimus 63 prognostic indicators 63 Perforomist ™ Inhalation Solution 63 LEUKINE 63 haematological cancers 63 including eniluracil ADH 63 epithelial tumors 63 anti angiogenic agents 63 Symadex 63 miRNA biomarkers 63 Azedra 63 percutaneous biopsy 63 cytoreduction 63 VeriStrat 63 BHT DNA 63 hypervascular tumors 63 aerosolized AAT 63 cMET 63 miRview mets 62 Colon polyps 62 Tr DNA 62 esophagogastric 62 PORxin TM platforms 62 galiximab 62 diagnostic biomarker 62 busulfan 62 renin inhibition 62 DNA methylation biomarkers 62 BEXXAR Therapeutic Regimen 62 nonsmall cell lung cancer 62 immunosuppressive regimens 62 TTF Therapy 62 HER2 expression 62 PLX STROKE targeting 62 RNAi therapeutic targeting 62 ovarian endometrial 62 lupus renal disease 62 cellular immunotherapy 62 candidates Azedra TM 62 Nanobodies ® 62 oncologic outcomes 62 Trofex TM 62 Onko Sure ™ 62 either acutely decompensated 62 relapsed ALL 62 GI motility disorders 62 radiographic outcomes 62 Solazed TM 62 ALK inhibitors 62 investigational therapies 62 Pseudomonas aeruginosa infections 62 BRAF V# mutation 62 CRLX# 62 Pertuzumab 62 Nicole Onetto MD 62 hyperphenylalaninemia HPA due 62 adjuvant therapies 62 interferon beta therapy 62 treating neuropathic pain 62 Cardiotoxicity 62 metastatic gastric 62 thetreatment 62 Adnectin 62 mSEPT9 biomarker 62 Trofex 62 MTWA testing 62 lung pancreatic 62 Rosetta Genomics microRNA 62 multigene expression test 62 visit www.genenews.com 62 OvaRex R 62 candidate TNFerade biologic 62 JAK inhibitors 62 AlloMap 62 Metastatic colorectal cancer 62 Bezielle 62 Umbilical cord stem cells 62 therapeutic monoclonal antibody 62 multiplexed assays 62 Cerashield 62 Generx TM 62 Oral NKTR 62 Radical prostatectomy 62 squamous cell lung cancer 62 Hedgehog inhibitor 62 pharmacogenomic tests 62 Alessandro Riva 62 IMiDs 62 molecular biomarker 62 PORxin TM 62 systemic immunosuppressive drugs 62 molecular diagnostic assays 62 FFR measurements 62 Fludara ® 62 Initiate Clinical Trial 62 illumigene C. difficile 62 pharmacogenetic testing 62 NP2 Enkephalin 61 myelofibrosis polycythemia vera 61 atherosclerosis regression 61 erlotinib Tarceva ® 61 diagnostic assays 61 perfusion MRI 61 Cardio Vascu Grow 61 Anticalins R 61 Sentinel Lymph Node Biopsy 61 immunological diseases 61 tumor histology 61 vinca alkaloid 61 PressureWire 61 prognostic biomarkers 61 BrachySil TM 61 haematopoietic stem cell 61 KRAS status 61 Evoltra ® 61 Combivir Kivexa 61 relapsed SCLC 61 PGxPredict tests 61 Solazed 61 THR beta agonist 61 Mammostrat 61 AlloMap testing 61 PRESEPT study 61 refractory angina 61 breast cancer subtypes 61 Squamous 61 multiplex assays 61 budesonide foam 61 targeted radiotherapeutic 61 metaglidasen 61 predictive biomarker 61 stem cell transplantations 61 methylation biomarkers 61 immunochemical 61 NMR LipoProfile test 61 PROCHYMAL 61 sapacitabine CYC# 61 cervical prostate 61 monoclonal antibody therapies 61 pain palliation 61 aromatase inhibitors AIs 61 DNA methylation markers 61 myoblast therapy 61 clevidipine 61 precursor lesions 61 ONCONASE R 61 dasatinib Sprycel 61 EndoTAGTM 1 61 CINtec R 61 Li Fraumeni 61 Haptoglobin 61 Xelox 61 Provecta 61 ResponseDX ™ 61 include ColorectAlert TM 61 hepatocellular carcinoma liver 61 ESBA# 61 taxane therapy 61 echocardiographic parameters 61 pharmacogenomic translational research 61 PITX2 61 radiation chemoradiation 61 Provectus Pharmaceuticals specializes 61 Bayer HealthCare Onyx Pharmaceuticals 61 M# rationally 61 pancreatic adenocarcinoma 61 Fetal Fibronectin Test 61 hematological parameters 61 carcinoids 61 ATIR ™ 61 PSMA ADC 61 CCR9 antagonist 61 periodically reassessed 61 HIFU therapy 61 Canvaxin TM 61 Vidaza ® 61 demonstrated antitumor activity 61 antiangiogenic therapy 61 CellPort Technologies 61 postoperative chemotherapy 61 refractory chronic lymphocytic 61 immunochemical fecal occult 61 OncoVEX GM CSF 61 treating cancerous tumors 61 Hepatocellular Carcinoma HCC 61 colorectal bladder 61 HER2 positive cancers 61 medically inoperable 61 histological subtypes 61 hematopoietic cell 61 Myocet 61 VBLOC TM 61 thiopurine drugs 61 metabolomic profiling 61 NMP# 61 ReN# therapy 61 HepaMate 61 EMPOWER ™ 61 pancreatic prostate 61 BREVAGen ™ 61 metabolomic profiles 61 ENMD # 61 basal cell nevus syndrome 61 Naive Patients 61 hematologic disorders 61 biomarker assays 61 constipation OIC 61 ATTR CM 61 gefitinib Iressa 61 castrate resistant 61 efaproxiral 61 alvespimycin 61 thalidomide Thalomid 61 NASH Huntington 61 TransVax ™ 61 variant angina 61 hepatic lesions 61 p# inhibitor 61 Alocrest 61 pre malignant lesions 61 oral talactoferrin 61 Theranostics 61 R sorafenib tablets 61 angiographic outcomes 61 papillary renal cell carcinoma 61 hA# 61 ALN PCS 61 P2V TM 61 refractory colorectal cancer 61 bioFILM PA ™ 61 dirucotide MBP# 61 novel VDA molecule 61 hematological malignancy 61 Octreolin 61 Tekamlo 61 Electronic Brachytherapy 61 molecular diagnostic assay 61 ADAMTS# 61 pyridostigmine 61 immunologic diseases 61 validating biomarkers 61 Xanafide 61 spinal metastases 61 Exelixis compounds 61 MAGE A3 ASCI 61 gastro intestinal inflammation 61 molecular abnormalities 61 Personalized Immunotherapy 60 Tectin TM 60 smoldering multiple myeloma 60 transplantation HCT 60 Prodarsan R 60 Zevalin consolidation 60 radiochemotherapy 60 ImmuKnow 60 Panzem 60 HIV tropism 60 Cervista HPV HR 60 chemistry microbiology immunology 60 Phase #/#a trial 60 DermaVir Patch 60 colorectal lung 60 CD# CEA 60 multi analyte 60 GAMMAGARD 60 FullTerm 60 Poly ICLC 60 gynecologic procedures 60 antiplatelet medications 60 Corgentin 60 Alequel 60 ELACYT 60 Flow cytometry 60 TRIST study 60 JAK2 inhibitors 60 ChronVac C R 60 chronic myocardial ischemia 60 Surgical resection 60 liver metastasis 60 immunomodulators 60 Spartan RX CYP#C# 60 congenital toxoplasmosis 60 skeletal metastases 60 miRview ™ squamous 60 Zemiva TM 60 AttoSense 60 ovarian breast 60 HIV coinfected 60 Smac mimetics 60 standard chemotherapy regimen 60 immunosuppression therapy 60 Anticalins ® 60 Genetic variants 60 repair TEVAR 60 hypereosinophilic syndrome 60 miRview TM 60 zileuton injection 60 radiolabeled TM# 60 transrectal ultrasound guided 60 Non inferiority 60 NuroPro R 60 Ribavirin causes 60 STRIDE PD 60 LungExpress Dx 60 NPM1 mutation 60 cannabinor 60 riociguat 60 calcineurin inhibitors 60 urolithiasis 60 ApoB SNALP 60 HERmark assay 60 completely resected 60 coagulation abnormalities 60 serum phosphorous 60 AFRS TM 60 CA9 SCAN 60 metabonomics 60 paclitaxel Taxol ® 60 pediatric malignancies 60 MyVax R 60 multi factorial disease 60 Menopausal hormone therapy 60 Alimentary Tract 60 endothelin antagonist 60 pediatric acute lymphoblastic 60 HLA typing 60 MDS AML 60 TKM PLK1 60 Oncotype DX ® 60 LAB CGRP 60 Campath alemtuzumab 60 PROSTVAC VF 60 Dr. Cassian Yee 60 nonpharmacologic 60 VANTAS ® 60 Mepact 60 Nothing Wadden 60 Tykerb lapatinib 60 TBC# 60 exemestane Aromasin 60 preoperative staging 60 BC SeraPro 60 refractory metastatic 60 miRview ™ mets 60 direct thrombin inhibitors 60 HCV protease inhibitors 60 clinically validated 60 Leukemias 60 metastatic renal 60 KRAS mutations 60 HepaMate ™ 60 HGS# 60 differentiated thyroid 60 diagnostic modality 60 Hair follicle 60 bronchoscopic procedures 60 MCSP respectively 60 BC SeraPro ™ 60 genomic biomarker 60 chemotherapeutic regimen 60 Previstage TM GCC 60 breast pancreatic 60 Genetic predisposition 60 proton MR spectroscopy 60 pharmacokinetic equivalence 60 biologic therapeutics 60 SERCA2a 60 gastrointestinal mucositis 60 Platinol ® cisplatin 60 nalbuphine ER 60 pertuzumab 60 Ectopic pregnancy 60 encapsulates siRNAs 60 standard chemotherapy regimens 60 CLIA certified laboratories 60 anti angiogenic drugs 60 castration resistant hormone refractory 60 MTHFD1L gene 60 Shortened telomeres 60 xTAG RVP 60 leukemia multiple myeloma 60 NAVISTAR R 60 multi factorial diseases 60 cardiac perfusion 60 pelvic malignancies 60 multitargeted 60 GEM OS2 60 oral anticoagulation 60 candidemia 60 PDE# inhibitors 60 hepatorenal syndrome 60 tubulin inhibitor 60 renal denervation 60 trastuzumab Herceptin ® 60 pharmacodynamic parameters 60 antiangiogenesis therapies 60 Septin9 biomarker 60 invasive lobular carcinoma 60 chemosensitivity 60 Warfarin Coumadin 60 metastatic colorectal 60 Aggrastat ® tirofiban hydrochloride 60 KRAS mutant 60 obstructive coronary artery 60 Eraxis 60 Chronic pancreatitis 60 HIV RDEA# 60 lipid lowering therapies 60 Zemplar Capsules 60 Telatinib 60 DCVax R 60 CMV vaccine 60 intra abdominal abscess 60 APTIMA HPV 60 pharmacogenetic test 60 SERMs 60 Achieves Primary Endpoint 60 immatics 60 VerifyNow System 60 histological subtype 60 biomarker validation 60 ER CHOP 60 ChemoFx 60 Adjuvant chemotherapy 60 microRNA profiling 60 Endoscopic ultrasound 60 PathFinderTG 60 IDI MRSA 60 QTinno TM 60 polyomavirus nephropathy 60 HQK 60 Circulating tumor cells 60 cytoreductive surgery 60 my3KG 60 manufactures minimally invasive 60 VitiGam 60 colonoscopic 59 HIPEC 59 Masimo SpHb 59 TTR amyloidosis 59 concurrent chemoradiation 59 warfarin dosing 59 IGIV therapy 59 intraoperative radiotherapy 59 Gamunex C 59 Interferon beta 59 oncology virology 59 malignant pleural mesothelioma 59 colorectal cancer liver metastases 59 multivessel coronary artery 59 cardio renal 59 BRACAnalysis ® 59 Panzem NCD 59 Amgen Neulasta R 59 sumatriptan DosePro 59 HERmark 59 next generation URAT1 59 MitraClip device 59 histologies 59 MastaScope 59 MGMT methylation 59 LHRH receptor positive 59 epigenetic therapeutics 59 secondary amenorrhea 59 Insegia 59 MET amplification 59 imexon 59 VelaShape ™ 59 recurrent glioblastoma multiforme 59 bardoxolone methyl 59 HE4 test 59 Azedra TM 59 Anthracycline 59 transfusion syndrome 59 PreGen Plus 59 sarcoma melanoma 59 Smac mimetic 59 lintuzumab SGN 59 drug Treanda 59 FUSILEV enhances 59 elacytarabine 59 hematopoietic cancers 59 receptor tyrosine kinase inhibitor 59 pretransplant 59 Anti Bacterial Envelope 59 relapsed leukemia 59 oncolytic virus therapies 59 MGd 59 glial tumors 59 advanced medullary thyroid 59 breast endometrial 59 anticlotting drugs 59 ResponseDX 59 mTOR inhibitors 59 miRview TM mets 59 CIMZIA ™ 59 gemcitabine carboplatin 59 OHR/AVR# 59 Viprovex TM 59 QuadraSphere 59 OncoVEX 59 neuroendocrine cancers 59 velafermin 59 5q deletion 59 samalizumab 59 genomic profiling 59 RLY# 59 Islet transplantation 59 Onconase 59 treat chronic sinusitis 59 endosomal release 59 deforolimus 59 evaluating tivozanib 59 patient subpopulations 59 aerosolized KL4 surfactant 59 EXACT Sciences technologies 59 chronic periodontitis 59 CMV infections 59 commercialize CorMedix drug 59 IMiDs ® compound 59 solid organ transplantation 59 MyVax ® 59 CYP#D# genotype 59 quantitative gene expression 59 plus dacarbazine 59 SNT MC# 59 Vaxfectin TM 59 Selzentry Celsentri 59 ferroportin levels 59 forodesine 59 diabetic kidney 59 intravascular hemolysis 59 novel oral anticoagulant 59 IgG1 antibodies 59 calcineurin inhibitor 59 recombinant PSMA vaccine 59 humanised monoclonal antibody 59 macrovascular events 59 lymphomas leukemias 59 CCR5 receptor antagonist 59 urine dipstick 59 TriGrid 59 recurrent metastatic 59 prognostic variables 59 radiotherapy RT 59 CancerGuide 59 Xcellerated T Cells 59 PET tracers 59 left ventricular diastolic 59 reagent kits 59 multicenter clinical trials 59 tissue oxygenation 59 VitiGam TM 59 locoregional recurrence 59 systemic ALCL 59 Factor Xa inhibitors 59 postoperative radiotherapy 59 T1c 59 dopaminergic therapy 59 VITAL Trial 59 aldehyde dehydrogenase ALDH2 deficiency 59 circulating endothelial cells 59 alpha1 antitrypsin deficiency 59 Litx 59 immunodeficiency disorders 59 vascular anatomy 59 dosimetric 59 Neo Bladder Augment 59 pharmacogenomic testing 59 Lorianne Masuoka MD 59 HuMax TAC 59 MammaPrint ® 59 GRN# 59 Transplant Rejection 59 Hemospan 59 Immunotherapeutic 59 Nanobody R 59 artery stenting 59 NOX E# 59 EGFr expressing metastatic colorectal 59 MassARRAY platform 59 Hemopurifier TM 59 OncoVex 59 molecular assays 59 apomorphine hydrochloride 59 Neuradiab 59 biologic pathways 59 Minimally invasive procedures 59 Kathy Giusti myeloma 59 Elocalcitol 59 T#I [002] 59 haematologic 59 undergo prostate biopsy 59 clinically localized prostate 59 LungExpress Dx TM 59 EGFR tyrosine kinase inhibitors 59 glycosylated hemoglobin levels 59 intestinal mucosal 59 TPI ASM8 59 EMPOWER TM 59 underwent prostate biopsy 59 adjuvant cisplatin 59 acyclovir Lauriad R 59 CytoCore develops cost 59 TQT studies 59 Acute leukemia 59 AbD Serotec segment 59 Bioaccelerate compounds under 59 LNP formulations 59 favorable pharmacokinetic profile 59 prostate cancer CaP 59 small molecule activators 59 Phase #b/#a clinical 59 chlamydial 59 Archexin 59 nonsquamous 59 MDx tests 59 pancreatic ductal 59 thrombophilia 59 DCVax R L 59 Tekmira SNALP technology 59 tamoxifen Nolvadex ® 59 epigenetic therapies 59 antiemetics 59 tumor biopsies 59 Allovectin 7 R 59 rheumatologic 59 MP4OX 59 KRAS oncogene 59 coronary stent merged 59 endothelin antagonists 59 vivo preclinical 59 HuMax 59 PANVAC VF 59 sargramostim 59 coronary CTA 59 pancreatic lung 59 indolent follicular non 59 reduce serum phosphate 59 abnormal p# 59 Nanobody 59 haematologic malignancies 59 monoclonal antibody therapeutics 59 Glioblastoma multiforme GBM 59 TRO# 59 underwent resection 59 Nanobody ® 59 neuro stimulation 59 neoplastic diseases 59 proteomics bioinformatics 59 serological tests 59 TRIOLEX HE# 59 Pneumococcal vaccines 59 MTP inhibitor 59 nucleotide analog 59 throughput RNAi 59 motesanib 59 OTCBB PWRM.OB 59 anti CD# antibodies 59 mSEPT9 59 GeneSightRx 59 cediranib 59 FDG-PET/CT 59 #F FDG PET 59 GVAX Pancreas Vaccine 59 clinically differentiated 59 ularitide 59 prospectively stratified 59 latent tuberculosis TB 59 endoglin 59 dialed Ybarra 59 electrocardiography ECG 59 CBLC# 59 ThinPrep Pap Test 59 stage IIIB IV 59 anemia thrombocytopenia 59 RNAi therapeutic platform 59 Rectal cancer 59 biostatistical analysis 59 chemotherapeutic regimens 59 Avastin Tarceva 59 Myelodysplastic syndromes MDS 59 antiphospholipid syndrome 59 ImmuKnow R 59 renal cell carcinomas 59 chronic thromboembolic pulmonary 59 Myelodysplastic syndromes 59 Bucindolol 59 OMP #M# 59 EarlyCDT Lung 59 DCVax ® 59 atherothrombotic disease 59 HGS ETR1 mapatumumab 59 HemeScan 59 BRAF mutated 59 primary hyperparathyroidism 59 XmAb 59 Myocardial Perfusion Imaging 59 biomarkers predictive 59 Dyax phage display 59 Prodarsan ® 59 TNF alpha antagonist 59 regorafenib 59 vemurafenib 59 Tumor Response 59 MYDICAR ® 59 CCX# 59 rxRNA 59 OMNARIS HFA 59 DNAwithPap TM Test 59 metastatic carcinoid 59 VKORC1 59 Trastuzumab DM1 59 immunosuppressive therapies 59 pharmacodynamic markers 59 SSc 59 hormone receptor negative 59 oral prodrug 59 ASONEP TM 59 antiangiogenic drugs 59 BRAF inhibitors 59 transplantation HSCT 58 preoperative chemotherapy 58 tumor subtypes 58 ColoMarker 58 EchoCRT 58 PREVU x 58 Relapsing remitting MS 58 lymphoid tumors 58 HBV infections 58 ganaxolone 58 Secondary efficacy endpoints 58 Oncotype DX breast cancer 58 immunosuppressive medications 58 NB S# strontium malonate 58 KRAS mutation status 58 Acute myelogenous leukemia 58 operable breast cancer 58 putative biomarkers 58 ovarian pancreatic 58 anticancer therapeutics 58 multicenter trials 58 monoclonal antibody MAb 58 antiproliferative effects 58 Capsule endoscopy 58 AMPK activators 58 nomograms 58 metastatic castration resistant 58 sorafenib tablets 58 novel radiopharmaceuticals 58 candidate CRLX# 58 curative therapies 58 catheter ablations 58 invasive candidiasis 58 clinico pathological 58 INTEGRILIN R eptifibatide Injection 58 HER2 positivity 58 acetonide FA 58 metaplasia 58 renal cortical 58 novel therapeutic antibodies 58 nonalcoholic steatohepatitis NASH 58 SinuNase TM 58 imatinib Gleevec 58 cancer immunotherapies 58 xTAG 58 CR# vcMMAE 58 GRNOPC1 contains 58 Src inhibitors 58 renal biopsy 58 neratinib 58 opioid tolerant adult 58 lapatinib Tykerb 58 Tasigna prolongs 58 accumulate preferentially 58 noninvasive diagnostic 58 Transcatheter aortic valve implantation 58 renal tumors 58 Thiarabine 58 Flexible sigmoidoscopy 58 multiplex PCR 58 everolimus eluting stents 58 Quinamed 58 ClearPath HDR 58 antibody mediated 58 neovascularisation 58 NATRECOR ® 58 product ColonSentry TM 58 Combo Stent 58 presymptomatic 58 proteomic biomarkers 58 personalized immunotherapy 58 antitumour 58 humanized therapeutic 58 ANAVEX #-# [001] 58 CTAP# 58 Capesaris 58 EUS FNA 58 diseases fat malabsorption 58 INxin 58 intracranial stenosis 58 illumigene 58 Accelerated Partial Breast Irradiation 58 histologic subtype 58 recurrent bladder 58 Liver transplantation 58 ZFP Therapeutics 58 miRview TM squamous 58 Roche AmpliChip 58 PCA3 assay 58 catheter occlusion 58 multifactorial disease 58 BACcel ™ system 58 Sapacitabine 58 TNF blocker therapy 58 ionotropic 58 complete cytogenetic response 58 chemoresistant 58 CPAP adherence 58 ARIKACE ™ 58 revascularization procedures 58 warfarin dosage 58 Amplimexon 58 EGFR inhibitors 58 delivers fluocinolone acetonide FA 58 PD2i Analyzer 58 co receptor tropism 58 GAP #B# 58 colorectal liver metastases 58 Azedra ™ 58 faulty BRCA genes 58 bronchogenic carcinoma 58 aromatase inhibitor therapy 58 lymph node biopsies 58 ® bortezomib 58 bevacizumab Avastin ® 58 Dural Sealant 58 vaso occlusive crisis 58 PITX2 methylation 58 coronary computed tomography 58 Inhaled corticosteroids 58 Biomerk Tumorgrafts 58 brand ciclesonide HFA 58 BRAF gene mutations 58 enzastaurin 58 ALSYMPCA 58 monoclonal gammopathy 58 sentinel lymph node biopsy 58 biochemical profiling 58 liposomal formulation 58 LungSign TM 58 Uterine cancer 58 differential gene expression 58 percutaneous cryoablation 58 K RAS 58 basal cell carcinoma squamous 58 familial hypercholesterolemia FH 58 BioMAP ® Systems 58 Cloretazine 58 kidney allograft 58 induce remission 58 farletuzumab 58 trastuzumab Herceptin R 58 Predictive modeling 58 neuropsychiatric diseases 58 immune modulating 58 candidate alferminogene tadenovec 58 SELDI TOF MS 58 Pulmotype 58 HSP# inhibitors 58 silico prediction 58 stent DES 58 gene expression assays 58 EC Cysteamine 58 interferon alpha IFN 58 letrozole Femara 58 advanced adenomas 58 Allovectin 7 ® 58 HCV antiviral 58 Inflammatory diseases 58 endometrial ovarian 58 axillary dissection 58 BrachySil ™ 58 Spectranetics laser 58 Gastrointestinal Stromal Tumors 58 Ventricular Arrhythmias 58 Kit v2 58 NuroPro PD 58 octreotide implant 58 MelaFind R 58 Patrick Plewman 58 TLR antagonists 58 ImmunoVEX 58 Cell Lymphoma CTCL 58 TRIOLEX HE# APOPTONE HE# 58 lenalidomide Revlimid R 58 diagnose coronary artery 58 ofpatients 58 B7 H3 58 Artificial pancreas 58 engineered RAP peptides 58 risk stratification 58 LymphoStat B belimumab 58 drug figitumumab 58 AA Amyloidosis 58 benign prostatic hyperplasia enlarged 58 Shows Promise Against 58 recurrent NSCLC 58 EGFR TKIs 58 mechanistic insights 58 MediGene focuses 58 lenalidomide dexamethasone 58 Shark cartilage 58 Fx #A 58 underwent surgical resection 58 novel immunotherapies 58 PDE4 inhibitors 58 thrombolytic agents 58 inhaled corticosteroid therapy 58 ZACTIMA TM ZD# 58 Soliris eculizumab